| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |